No New Trial For Abbott Whistleblower In $219M Stent Row

By John Kennedy · May 18, 2016, 4:49 PM EDT

The whistleblower who in April lost a $219 million suit against Abbott Laboratories over allegedly improperly marketed bile duct stents won't get a new trial, a Texas federal judge ruled on...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order on Motion for New Trial

Case Information

Case Title

USA v. Abbott Laboratories et al

Case Number

Court

Texas Northern

Nature of Suit

Other Statutes: Other Statutory Actions

Date Filed

September 26, 2006

Recent Articles By John

March 06, 2019
Ky. Hospital Sues Travelers For $10M Over Shoddy Building
July 03, 2018
NY Panel Revives NYU Sandy Damage Claims Against Turner
March 01, 2018
HHS Must Reconsider Formula For ACA Payments
February 13, 2018
11th Circ. Asked To Rehear Amgen, Pfizer Win In Enbrel Suit
February 07, 2018
Epic Beats Whistleblower's 'Woefully Deficient' FCA Suit
February 06, 2018
UPenn Hospital Can't Yet Exit Brain-Damage Suit, Judge Says
February 06, 2018
Docs Call Cigna's 11th Circ. Appeal Over $25M Deal Premature
February 05, 2018
Ex-Doc Gets 8 Years For Fraud, Illegally Dispensing Opioids
February 05, 2018
Navajo Nation Sues HHS Over $7.2M Education Program Cut
February 02, 2018
2nd Circ. Affirms Dismissal Of Dr. Scholl's Class Action